RDD Pharma, a developer of intra-anal drug delivery devices that deliver a drug to the anal canal, has raised $7.15 million in a financing round led by OrbiMed Advisors LLC. RDD Pharma was founded in 2009 at the Ofakim Hi-Tech Ventures incubator and is based in Ofakim, Israel. The company also develops a drug for the treatment spinal cord injury related fecal incontinence. RDD Pharma completed a proof of concept trial in healthy subjects in Israel and met with the FDA on the protocols for further clinical trials.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments